Tinnitus as an indication of therapeutic serum salicylate levels.
about
Effect of high-dose aspirin on CYP2E1 activity in healthy subjects measured using chlorzoxazone as a probeDiflunisal, a new-acting analgesic and prostaglandin inhibitor: effect of concomitant acetylsalicylic acid therapy on ototoxicity and on disposition of both drugsConcentration-response relationships for salicylate-induced ototoxicity in normal volunteers.Salicylate toxicity model of tinnitus.Review of salicylate-induced hearing loss, neurotoxicity, tinnitus and neuropathophysiology.Tinnitus and hyperacusis involve hyperactivity and enhanced connectivity in auditory-limbic-arousal-cerebellar network.A case of bilateral sudden hearing loss and tinnitus after salicylate intoxicationLong-term administration of salicylate enhances prestin expression in rat cochleaGLAST Deficiency in Mice Exacerbates Gap Detection Deficits in a Model of Salicylate-Induced Tinnitus.Central Nervous Activity upon Systemic Salicylate Application in Animals with Kanamycin-Induced Hearing Loss--A Manganese-Enhanced MRI (MEMRI) StudyEffects of long-term salicylate administration on synaptic ultrastructure and metabolic activity in the rat CNS.Local Application of Sodium Salicylate Enhances Auditory Responses in the Rat's Dorsal Cortex of the Inferior Colliculus.A novel behavioral assay for the assessment of acute tinnitus in rats optimized for simultaneous recording of oscillatory neural activity.Animal models of subjective tinnitus.A novel behavioural approach to detecting tinnitus in the guinea pig.Altered neuronal intrinsic properties and reduced synaptic transmission of the rat's medial geniculate body in salicylate-induced tinnitus.Human Brain Imaging of Tinnitus and Animal ModelsVigabatrin, a GABA transaminase inhibitor, reversibly eliminates tinnitus in an animal modelSalicylate ototoxicity in patients with rheumatoid arthritis: a controlled study.Cisplatin-induced hyperactivity in the dorsal cochlear nucleus and its relation to outer hair cell loss: relevance to tinnitus.Effects of nimodipine on salicylate ototoxicity.Symptomatic salicylate ototoxicity: a useful indicator of serum salicylate concentration?Tinnitus as a measure of salicylate toxicity in the overdose settingPlastic changes in the central auditory system after hearing loss, restoration of function, and during learning.A review of non-steroidal anti-inflammatory drugs.Alterations in average spectrum of cochleoneural activity by long-term salicylate treatment in the guinea pig: a plausible index of tinnitus.Plastic changes along auditory pathway during salicylate-induced ototoxicity: Hyperactivity and CF shifts.Long-term efficacy and safety of tolmetin sodium in treatment of geriatric patients with rheumatoid arthritis and osteoarthritis: a retrospective study.Salicylate measurement: clinical usefulness and methodology.Problems of antiarthritic therapy in the elderly.Salicylate-induced hyperacusis in rats: Dose- and frequency-dependent effects.Population pharmacodynamics: strategies for concentration-and effect-controlled clinical trials.Ototoxic effects of salicylates on the responses of single cochlear nerve fibres and on cochlear potentials.Hypotonic swelling of salicylate-treated cochlear outer hair cells.Paradoxical enhancement of active cochlear mechanics in long-term administration of salicylate.Effect of corticosteroid treatment on salicylate ototoxicity.Effects of the cannabinoid CB1 agonist ACEA on salicylate ototoxicity, hyperacusis and tinnitus in guinea pigs.Effects of salicylate on shape, electromotility and membrane characteristics of isolated outer hair cells from guinea pig cochlea.Electrocochleographic changes in acute salicylate overdosage.Letter: Clinical implications of variation in strength of adult aspirin dosage forms.
P2860
Q28194378-210CDCE5-1A5D-4C4F-893F-0B0F38113EA3Q28323987-1B26D9B5-FDB5-4B18-8F86-186BE2289BF6Q28354350-3BDACC22-1E42-40E6-AFD5-2C1502D55129Q28383940-7C6DD517-CA7C-40CA-9B0E-CBA475E09903Q28386219-2B67BBBD-979A-4046-BA89-F46EF8FC3F84Q28393783-B282DEF3-07C9-4FCB-BB63-76801B457C79Q28396654-E38BF3EF-529E-4113-8335-1A9EEE1E2295Q28568941-A124B855-5BE9-4F86-BAA0-55BADE7DC225Q30375593-2199E7CC-BA08-4736-BDE7-EE7BCBC99C69Q30385322-0DCF8572-06E7-4448-9315-24819A128582Q30385641-A04D7C36-C0F9-4AFC-BD72-27A753F4041EQ30423919-F3D0A8B6-F55B-4B8C-9CC3-98141D37DAFCQ30428468-799198CA-735F-49B3-97E8-4B53CA0CF676Q30438527-33310395-87EB-4674-87D5-6BEFBC6843F6Q30456272-CB9AEFF5-3E74-4451-898C-8D29EDF05CC5Q30462510-4FE97486-6D72-4279-B1B8-7C91140FA189Q30491843-BF65DB8F-8334-47E9-8D25-6A3F16A6AD1DQ30492518-9AA998B2-1695-4E4B-AD5E-370404D81293Q30500610-A24052AB-CEF7-431C-924E-68C87B67B38CQ30841065-E4E40ABC-7D93-41B8-B34A-5C569D7730B6Q31122317-E36A2F15-A270-4C64-B58D-2BC9D6695201Q33563916-3917B8B1-A23F-485D-8664-3EDCCE3E7734Q34609404-27359B80-5F9F-4B71-9507-2AC9E0E81AD5Q34711195-BBB77DA5-4766-461A-8795-F83AD9FD6E8CQ37833916-63B21D33-5FE1-45A0-9AD3-B20511099519Q38549704-DBFFEE2C-AAAE-4973-B4A8-2EFB681A09CFQ39090494-61128F5E-B1A8-4F1A-9EE6-1878E73CFAE5Q39559042-0F3C0E38-6B10-409B-B2D2-BD0889CEB5C4Q39662493-8A953AF3-A71B-4622-A6BE-A58C16A40C68Q40170807-E17713C8-D41A-4A4A-ACF2-1C01EBF07399Q40465803-25EAC263-199C-44D1-8F58-AE1E645A3655Q41084265-E9DD73A4-B41C-4880-B853-4744FC597CFDQ41622581-DC9BF8AF-2034-4574-A146-1EAF536A9F99Q42620441-67C48A98-6F4E-44A8-B168-BDD98EA70CAEQ45182379-E98B1863-FD8A-45BD-8305-772E04659B96Q46895978-4F1DC2E0-ECF1-4B92-B517-ED49E6A096D4Q47107982-0C2BCFA6-8D45-4F4F-B160-61E4BC3E0274Q50546568-52DBE8B5-AA14-4B8D-A4A3-E811F78D6CD9Q50581905-A7578C17-6C28-40A5-988C-E44D71FB4741Q54470456-A685A000-1463-44F4-A111-545A36A651FE
P2860
Tinnitus as an indication of therapeutic serum salicylate levels.
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
1973年论文
@zh
1973年论文
@zh-cn
name
Tinnitus as an indication of therapeutic serum salicylate levels.
@en
Tinnitus as an indication of therapeutic serum salicylate levels.
@nl
type
label
Tinnitus as an indication of therapeutic serum salicylate levels.
@en
Tinnitus as an indication of therapeutic serum salicylate levels.
@nl
prefLabel
Tinnitus as an indication of therapeutic serum salicylate levels.
@en
Tinnitus as an indication of therapeutic serum salicylate levels.
@nl
P2093
P1476
Tinnitus as an indication of therapeutic serum salicylate levels.
@en
P2093
P304
P356
10.1001/JAMA.1973.03230020014004
P407
P577
1973-10-01T00:00:00Z